Eczematoid graft-vs-host disease: A novel form of chronic cutaneous graft-vs-host disease and its response to psoralen-UV-A therapy

Archives of Dermatology

Volumn 143, Issue 9, 2007, Pages 1157-1162

  Creamer, Daniel ^a   Martyn Simmons, Claire L ^a   Osborne, Genevieve ^a   Kenyon, Michelle ^a   Salisbury, Jon R ^a   Devereux, Stephen ^a   Pagliuca, Antonio ^a   Ho, Aloysius Y ^a   Mufti, Ghulam J ^a   Du Vivier, Anthony W P ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALEMTUZUMAB; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; AZATHIOPRINE; BERGAPTEN; BUSULFAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; EMOLLIENT AGENT; FLUCONAZOLE; FLUDARABINE PHOSPHATE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENICILLIN V; PREDNISOLONE; PSORALEN; TACROLIMUS;

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ATOPY; CANCER REGRESSION; CLINICAL ARTICLE; DERMATITIS; ECZEMA; ECZEMATOID GRAFT VERSUS HOST DISEASE; ERYTHRODERMA; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN TISSUE; INFECTION COMPLICATION; LEUKEMIA RELAPSE; MALE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PUVA; REDUCED INTENSITY CONDITIONING; RISK FACTOR; TREATMENT RESPONSE; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ECZEMA; FEMALE; FICUSIN; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PHOTOSENSITIZING AGENTS; PUVA THERAPY;

EID: 34548817903     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.143.9.1157     Document Type: Article

References (15)

1. Billingham RE. The biology of graft-versus-host reactions. Harvey Lect. 1966-1967;62:21-78.
2. Ferrara JL, Deeg HJ. Graft-versus-host disease. N Engl J Med. 1991;324(10):667-674.
3. Johnson ML, Farmer ER. Graft-versus-host reactions in dermatology. J Am Acad Dermatol. 1998;38(3):369-396.
4. Hood AF, Soter NA, Rappeport J, Gigli I. Graft-versus-host reaction: cutaneous manifestations following bone marrow transplantation. Arch Dermatol. 1977;113(8):1087-1091.
5. Hymes SR, Turner ML, Champlin RE, Couriel DR. Cutaneous manifestations of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2006;12(11):1101-1113.
6. Ollivier I, Wolkenstein P, Gherardi R, et al. Dermatomyositis-like graft-versus-host disease. Br J Dermatol. 1998;138(3):558-559.
7. Girardi M, Herreid P, Tigelaar R. Specific suppression of lupus-like graft-versus-host disease using extracorporeal photochemical attenuation of effector lymphocytes. J Invest Dermatol. 1995;104(2):177-182.
8. Tanasescu S, Balguerie X, Thomine E, et al. Eczema-like cutaneous graft versus host disease treated by UV-B therapy in a 2-year-old child [in French]. Ann Dermatol Venereol. 1999;126(1):51-53.
9. Sloane JP, Thomas JA, Imrie SF, Easton DF, Powles RL. Morphological and immunohistological changes in the skin in allogeneic bone marrow recipients. J Clin Pathol. 1984;37(8):919-930.
10. Ho AY, Pagliuca A, Kenyon M, et al. Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning [published online ahead of print April 1, 2004]. Blood. 2004;104(6):1616-1623. doi:10.1182/blood-2003-12-4207.
11. Bellou A, Kanny G, Fremont S, Moneret-Vautrin DA. Transfer of atopy following bone marrow transplantation. Ann Allergy Asthma Immunol. 1997;78(5):513-516.
12. Sullivan KM, Parkman R. The pathophysiology and treatment of graft-versus-host disease. Clin Haematol. 1983;12(3):775-789.
13. Weinberg K, Blazar BR, Wagner JE, et al. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood. 2001;97(5):1458-1466.
14. McCormick LL, Zhang Y, Tootell E, Gilliam AC. Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma. J Immunol. 1999;163(10):5693- 5699.
15. van Reijsen FC, Bruijnzeel-Koomen CA, Kalthoff FS, et al. Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis. J Allergy Clin Immunol. 1992;90(2):184-193.